Robert J More - Net Worth and Insider Trading

Robert J More Net Worth

The estimated net worth of Robert J More is at least $97 Million dollars as of 2026-09-11. Robert J More is the Director of Tyra Biosciences Inc and owns about 3,823,425 shares of Tyra Biosciences Inc (TYRA) stock worth over $90 Million. Robert J More is the Director of Vir Biotechnology Inc and owns about 522,141 shares of Vir Biotechnology Inc (VIR) stock worth over $6 Million. Robert J More is also the Director of Glaukos Corp and owns about 5,000 shares of Glaukos Corp (GKOS) stock worth over $851,900. Besides these, Robert J More also holds Allakos Inc (ALLK) , Novation Companies Inc (NOVCQ) , Sienna Biopharmaceuticals Inc (SNNAQ) . Details can be seen in Robert J More's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert J More has not made any transactions after 2025-12-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Robert J More

Are these stocks worth buying? — GuruFocus analysis for each holding

- GF

TYRA Tyra Biosciences Inc

93% of holdings · $90.0M

VIR Vir Biotechnology Inc

6% of holdings · $5.5M

1% of holdings · $682K

1% of holdings · $852K

SNNAQ Sienna Biopharmaceuticals Inc

Robert J More Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert J More owns 9 companies in total, including Vir Biotechnology Inc (VIR) , Allakos Inc (ALLK) , and Sienna Biopharmaceuticals Inc (SNNAQ) among others .

Click here to see the complete history of Robert J More’s form 4 insider trades.

Insider Ownership Summary of Robert J More

Ticker	Company	Transaction Date	Type of Owner
VIR	Vir Biotechnology Inc	2021-07-29	director
ALLK	Allakos Inc	2021-03-05	10 percent owner
SNNAQ	Sienna Biopharmaceuticals Inc	2019-05-30	director
		2015-06-24	director
		2007-11-27	10 percent owner
		2006-05-09	10 percent owner
		2006-04-12	10 percent owner
		2004-05-12	10 percent owner
		2025-12-19	director & 10 percent owner

Robert J More Latest Holdings Summary

Robert J More currently owns a total of 6 stocks. Among these stocks, Robert J More owns 3,823,425 shares of Tyra Biosciences Inc (TYRA) as of December 19, 2025, with a value of $90 Million and a weighting of 92.73%. Robert J More owns 522,141 shares of Vir Biotechnology Inc (VIR) as of July 29, 2021, with a value of $6 Million and a weighting of 5.69%. Robert J More also owns 5,000 shares of Glaukos Corp (GKOS) as of June 24, 2015, with a value of $851,900 and a weighting of 0.88%. The other 3 stocks Allakos Inc (ALLK) , Novation Companies Inc (NOVCQ) , Sienna Biopharmaceuticals Inc (SNNAQ) have a combined weighting of 0.7% among all his current holdings.

Latest Holdings of Robert J More

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TYRA	Tyra Biosciences Inc	2025-12-19	3,823,425	23.54	90,003,425
VIR	Vir Biotechnology Inc	2021-07-29	522,141	10.58	5,524,252
GKOS	Glaukos Corp	2015-06-24	5,000	170.38	851,900
ALLK	Allakos Inc	2021-03-05	2,071,147	0.33	681,614
NOVCQ	Novation Companies Inc	2006-05-15	1,062,474	0.00	106
SNNAQ	Sienna Biopharmaceuticals Inc	2018-03-29	178,820	0.00	18

Holding Weightings of Robert J More

Robert J More Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert J More has made a total of 3 transactions in Tyra Biosciences Inc (TYRA) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Tyra Biosciences Inc is the sale of 10,000 shares on December 19, 2025, which brought Robert J More around $250,000.

According to the SEC Form 4 filings, Robert J More has made a total of 0 transactions in Vir Biotechnology Inc (VIR) over the past 5 years. The most-recent trade in Vir Biotechnology Inc is the sale of 11,670 shares on July 29, 2021, which brought Robert J More around $429,689.

According to the SEC Form 4 filings, Robert J More has made a total of 0 transactions in Glaukos Corp (GKOS) over the past 5 years. The most-recent trade in Glaukos Corp is the acquisition of 5,000 shares on June 24, 2015, which cost Robert J More around $90,000.

More details on Robert J More's insider transactions can be found in the Insider Trading History of Robert J More table.

Insider Trading History of Robert J More

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert J More Trading Performance

GuruFocus tracks the stock performance after each of Robert J More's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert J More is -21.82%. GuruFocus also compares Robert J More's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert J More within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert J More's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert J More

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-14.29
Relative Return to S&P 500(%)	-13.25

Get the full picture on these stocks

See GF Score, valuation, financials, and warning signs for every stock Robert J More owns.

- TYRA - VIR - GKOS - ALLK - SNNAQ

View TYRA Analysis

Robert J More Ownership Network

Ownership Network List of Robert J More

No Data

Ownership Network Relation of Robert J More

Robert J More Owned Company Details

What does Vir Biotechnology Inc do?

Who are the key executives at Vir Biotechnology Inc?

Robert J More is the director of Vir Biotechnology Inc. Other key executives at Vir Biotechnology Inc include SVP & Chief Accounting Officer Brent Sabatini , Chief Executive Officer Backer Marianne De , and EVP and Chief Medical Officer Mark Eisner .

Vir Biotechnology Inc (VIR) Insider Trades Summary

Over the past 18 months, Robert J More made no insider transaction in Vir Biotechnology Inc (VIR). Other recent insider transactions involving Vir Biotechnology Inc (VIR) include a net sale of 2,955,117 shares made by Softbank Vision Fund (aiv M1) L.p. , a net sale of 262,377 shares made by Vicki L Sato , and a net sale of 12,879 shares made by Brent Sabatini .

In summary, during the past 3 months, insiders sold 0 shares of Vir Biotechnology Inc (VIR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,474,355 shares of Vir Biotechnology Inc (VIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,474,355 shares.

Vir Biotechnology Inc (VIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vir Biotechnology Inc Insider Transactions

No Available Data

What does Allakos Inc do?

Who are the key executives at Allakos Inc?

Robert J More is the 10 percent owner of Allakos Inc. Other key executives at Allakos Inc include Chief Financial Officer Harlan Baird Radford , Chief Medical Officer Craig A. Paterson , and General Counsel and Secretary Margaret Nell Fitzgerald .

Allakos Inc (ALLK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Allakos Inc (ALLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Allakos Inc (ALLK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Allakos Inc (ALLK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Allakos Inc Insider Transactions

No Available Data

What does Sienna Biopharmaceuticals Inc do?

Who are the key executives at Sienna Biopharmaceuticals Inc?

Robert J More is the director of Sienna Biopharmaceuticals Inc. Other key executives at Sienna Biopharmaceuticals Inc include Chief Financial Officer Alexander Azoy , Chief Medical Officer Paul F. Lizzul , and director & President & CEO Iii Frederick Beddingfield .

Sienna Biopharmaceuticals Inc (SNNAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sienna Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Glaukos Corp do?

Who are the key executives at Glaukos Corp?

Robert J More is the director of Glaukos Corp. Other key executives at Glaukos Corp include Chief Development Officer Tomas Navratil , CFO & SVP Corporate Development Joseph E Gilliam , and SVP & Chief Financial Officer Alex R. Thurman .

Glaukos Corp (GKOS) Insider Trades Summary

Over the past 18 months, Robert J More made no insider transaction in Glaukos Corp (GKOS). Other recent insider transactions involving Glaukos Corp (GKOS) include a net sale of 64,971 shares made by Alex R. Thurman , a net sale of 24,780 shares made by Tomas Navratil , and a net sale of 103,415 shares made by Joseph E Gilliam .

In summary, during the past 3 months, insiders sold 129,022 shares of Glaukos Corp (GKOS) in total and bought 0 shares, with a net sale of 129,022 shares. During the past 18 months, 517,891 shares of Glaukos Corp (GKOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 517,891 shares.

Glaukos Corp (GKOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Glaukos Corp Insider Transactions

No Available Data

What does Orexigen Therapeutics Inc do?

Who are the key executives at Orexigen Therapeutics Inc?

Robert J More is the 10 percent owner of Orexigen Therapeutics Inc. Other key executives at Orexigen Therapeutics Inc include 10 percent owner Baupost Group Gp, L.l.c. , 10 percent owner Baupost Group Llc/ma , and 10 percent owner Seth A Klarman .

Orexigen Therapeutics Inc (OREXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Orexigen Therapeutics Inc (OREXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orexigen Therapeutics Inc (OREXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orexigen Therapeutics Inc (OREXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Orexigen Therapeutics Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Robert J More is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does Vanda Pharmaceuticals Inc do?

Who are the key executives at Vanda Pharmaceuticals Inc?

Robert J More is the 10 percent owner of Vanda Pharmaceuticals Inc. Other key executives at Vanda Pharmaceuticals Inc include SVP & GC and Secretary Daniel Patrick Mcguire , Senior VP & Medical Director Polymeropoulos Christos Vasilios Mihael , and VP and Chief People Officer Scott Laverne Howell .

Vanda Pharmaceuticals Inc (VNDA) Insider Trades Summary

Over the past 18 months, Robert J More made no insider transaction in Vanda Pharmaceuticals Inc (VNDA). Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 116,235 shares made by Mihael Hristos Polymeropoulos , a net sale of 42,442 shares made by Kevin Patrick Moran , and a net sale of 42,434 shares made by Timothy Williams .

In summary, during the past 3 months, insiders sold 0 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 351,342 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 40,000 shares were bought by its insiders, resulting in a net sale of 311,342 shares.

Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vanda Pharmaceuticals Inc Insider Transactions

No Available Data

What does NuVasive Inc do?

Who are the key executives at NuVasive Inc?

Robert J More is the 10 percent owner of NuVasive Inc. Other key executives at NuVasive Inc include SVP & People and Culture Michael Farrington , Chief Accounting Officer Marc W. Rosenbaum , and director & Chief Executive Officer James Christopher Barry .

NuVasive Inc (NUVA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NuVasive Inc (NUVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NuVasive Inc (NUVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NuVasive Inc (NUVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

NuVasive Inc Insider Transactions

No Available Data

What does Tyra Biosciences Inc do?

Who are the key executives at Tyra Biosciences Inc?

Robert J More is the director & 10 percent owner of Tyra Biosciences Inc. Other key executives at Tyra Biosciences Inc include Vice President & Finance (PAO) Yuliya Rueb , Chief Operating Officer Daniel Bensen , and Chief Operating Officer Bhavesh Ashar .

Tyra Biosciences Inc (TYRA) Insider Trades Summary

Over the past 18 months, Robert J More made 2 insider transaction in Tyra Biosciences Inc (TYRA) with a net sale of 256,871. Other recent insider transactions involving Tyra Biosciences Inc (TYRA) include a net sale of 281,000 shares made by Daniel Bensen , a net purchase of 1,561,335 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 75,687 shares made by Gilla Kaplan .

In summary, during the past 3 months, insiders sold 0 shares of Tyra Biosciences Inc (TYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 613,558 shares of Tyra Biosciences Inc (TYRA) were sold and 1,561,335 shares were bought by its insiders, resulting in a net purchase of 947,777 shares.

Tyra Biosciences Inc (TYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tyra Biosciences Inc Insider Transactions

No Available Data

Robert J More Mailing Address

Above is the net worth, insider trading, and ownership report for Robert J More. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert J More's mailing address is: Jackson Wy 83001.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.